A42
|
Aabel
|
2001
|
N
|
N
|
51
|
51
|
N
|
0.0
|
N
|
Daily symptom score (VAS)
|
Continuous
|
10 days
|
A43
|
Aabel
|
2000
|
N
|
Y
|
70
|
66
|
Y
|
5.7
|
N
|
Daily symptom score
|
Continuous
|
32 days
|
A44
|
Aabel
|
2000
|
N
|
Y
|
80
|
73
|
Y
|
8.8
|
N
|
Daily symptom score (VAS)
|
Continuous
|
10 days
|
A47
|
Baker
|
2003
|
N
|
Y
|
?
|
44
|
N
|
?
|
N
|
Revised Test Anxiety (RTA) scale
|
Continuous
|
4 days
|
A48
|
bBalzarini
|
2000
|
N
|
N
|
66
|
61
|
N
|
7.6
|
N
|
Index of Total Severity during Recovery (re: skin colour, temp, oedema, pigmentation)
|
Continuous
|
7–8 weeks
|
A49
|
bBeer
|
1999
|
N
|
N
|
40
|
40
|
N
|
0.0
|
Y
|
Time between to regular uterine contractions
|
Continuous
|
7 h or induction of labour
|
A50
|
Belon
|
2006
|
N
|
N
|
43
|
43
|
N
|
0.0
|
N
|
Reversal in expression of antinuclear antibody titre
|
Dichotomous
|
1 month
|
A51
|
Belon
|
2007
|
Y
|
N
|
39
|
25
|
N
|
35.9
|
N
|
Blood arsenic concentration
|
Continuous
|
2 months
|
A52
|
bBergmann (a)
|
2000
|
N
|
Y
|
?
|
37
|
N
|
?
|
N
|
Cycle normalisation
|
Dichotomous
|
3 months or 3 cycles
|
A52
|
bBergmann (b)
|
2000
|
N
|
Y
|
?
|
30
|
N
|
?
|
Y
|
Cycle normalisation
|
Dichotomous
|
3 months or 3 cycles
|
A53
|
Bernstein
|
2006
|
N
|
N
|
200
|
171
|
Y
|
14.5
|
N
|
Psoriasis Area Severity Index
|
Continuous
|
12 weeks
|
A55
|
Berrebi
|
2001
|
N
|
N
|
71
|
71
|
Y
|
0.0
|
N
|
Mammary pain (VAS)
|
Continuous
|
4 days
|
A56
|
Bignamini
|
1987
|
N
|
N
|
34
|
32
|
N
|
5.9
|
N
|
(Systolic) Blood pressure
|
Continuous
|
4 weeks
|
A59
|
bCialdella
|
2001
|
N
|
Y
|
96
|
61
|
N
|
36.5
|
Y
|
“Success rate” for clinical global impression
|
Dichotomous
|
30 days
|
A60
|
Clark
|
2000
|
Y
|
N
|
18
|
14
|
N
|
22.2
|
N
|
Daily pain (100 mm VAS)
|
Continuous
|
14 days
|
A272
|
Colau
|
2012
|
N
|
Y
|
108
|
101
|
Y
|
6.5
|
Y
|
Hot flash score
|
Continuous
|
12 weeks
|
A61
|
Cornu
|
2010
|
Y
|
Y
|
92
|
92
|
Y
|
0.0
|
Y
|
Cumulated blood loss at drain removal
|
Continuous
|
Up to 7 d
|
A62
|
bDiefenbach
|
1997
|
N
|
N
|
258
|
209
|
Y
|
19.0
|
Y
|
Treatment success (‘very good’ + ‘good’ results) – physician-assessed
|
Dichotomous
|
Up to 3 weeks
|
A63
|
bErnst
|
1990
|
N
|
N
|
122 a
|
122 a
|
N
|
0.0
|
N
|
Venous filling time
|
Continuous
|
24 days
|
A64
|
bFerley
|
1989
|
N
|
N
|
478
|
462
|
Y
|
3.3
|
N
|
Proportion of patients recovered (from 5 cardinal symptoms and from temp > 37.5)
|
Dichotomous
|
By 48 h
|
A67
|
Frass
|
2005
|
N
|
N
|
55
|
50
|
N
|
9.1
|
N
|
Total volume of tracheal secretions per day
|
Continuous
|
2 days
|
A68
|
bFreitas
|
1995
|
N
|
N
|
86
|
69
|
Y
|
19.8
|
N
|
Score of intensity, frequency and duration of symptoms
|
Continuous
|
6 months
|
A69
|
Friese
|
2007
|
N
|
N
|
144
|
68
|
Y
|
52.8
|
Y
|
Sinusitis symptoms score
|
Continuous
|
21 days
|
A70
|
bFriese
|
1997
|
N
|
Y
|
97
|
82
|
Y
|
15.5
|
N
|
Frequency of non-adenoidectomy (imputed)
|
Dichotomous
|
3 months
|
A74
|
Gerhard (a)
|
1998
|
N
|
Y
|
38
|
28
|
N
|
26.3
|
N
|
Frequency of pregnancy
|
Dichotomous
|
3 months
|
A74
|
Gerhard (b)
|
1998
|
N
|
Y
|
27
|
21
|
N
|
22.2
|
N
|
Frequency of pregnancy
|
Dichotomous
|
3 months
|
A74
|
Gerhard (c)
|
1998
|
N
|
Y
|
31
|
17
|
N
|
45.2
|
N
|
Frequency of pregnancy
|
Dichotomous
|
3 months
|
A75
|
GRECHO
|
1989
|
N
|
Y
|
300
|
300
|
Y
|
0.0
|
N
|
Number of hours from operation until first stool
|
Continuous
|
Up to c.100 h
|
A274
|
Harrison
|
2013
|
Y
|
N
|
34
|
28
|
N
|
17.6
|
N
|
Sleep onset latency
|
Continuous
|
28 days
|
A76
|
Hart
|
1997
|
N
|
N
|
93
|
73
|
Y
|
21.5
|
N
|
Frequency of improved pain score (VAS)
|
Dichotomous
|
Duration of 5 days
|
A78
|
Hitzenberger
|
2005
|
N
|
Y
|
?
|
?
|
-
|
?
|
N
|
Blood pressure
|
Continuous
|
6 weeks
|
A79
|
bHofmeyr
|
1990
|
Y
|
N
|
162
|
161
|
Y
|
0.6
|
N
|
Daily questionnaire responses: those without moderate/severe perineal pain
|
Dichotomous
|
4 days
|
A80
|
Jacobs
|
2006
|
N
|
N
|
292
|
265
|
Y
|
9.2
|
Y
|
Duration of diarrhoea
|
Continuous
|
Up to 7 days
|
A81
|
Jacobs
|
2007
|
Y
|
N
|
60
|
58
|
N
|
1.7
|
N
|
No. of days until no pain or fever for at least two consecutive days
|
Continuous
|
Up to 1 weeks
|
A83
|
bKaziro
|
1984
|
N
|
N
|
77
|
77
|
Y
|
0.0
|
N
|
Pain score (VAS): Numbers without moderate/severe pain (imputed)
|
Dichotomous
|
8 days
|
A84
|
Khuda-Bukhsh
|
2005
|
Y
|
N
|
55
|
55
|
N
|
0.0
|
N
|
Urine arsenic concentration (imputed)
|
Continuous
|
11 days
|
A85
|
Khuda-Bukhsh
|
2011
|
Y
|
N
|
28
|
14
|
N
|
50.0
|
N
|
Urine arsenic concentration
|
Continuous
|
2 months
|
A86
|
Kim
|
2005
|
Y
|
Y
|
40
|
34
|
N
|
15.0
|
Y
|
Rhinoconjunctivitis Quality-of-Life Questionnaire (RQLQ total symptoms)
|
Continuous
|
4 weeks
|
A88
|
Kolia-Adam
|
2008
|
N
|
N
|
30
|
30
|
N
|
0.0
|
N
|
Hours of sleep per night
|
Continuous
|
8 weeks
|
A89
|
Kotlus
|
2010
|
N
|
N
|
60
|
57
|
N
|
5.0
|
N
|
Area of ecchymosis
|
Continuous
|
7 days
|
A91
|
Labrecque
|
1992
|
N
|
Y
|
174
|
162
|
Y
|
6.9
|
N
|
Proportion of pts with healed warts (physician assessment)
|
Dichotomous
|
18 weeks
|
A92
|
bLeaman
|
1989
|
N
|
N
|
34
|
34
|
N
|
0.0
|
N
|
Pain (0-10 VAS) - area-under-the-curve
|
Continuous
|
6 h
|
A93
|
Lewith
|
2002
|
N
|
N
|
242
|
202
|
Y
|
16.5
|
Y
|
Asthma VAS (imputed)
|
Continuous
|
16 weeks
|
A94
|
Lipman
|
1999
|
N
|
N
|
101
|
90
|
Y
|
10.9
|
N
|
Average snoring score computed from responses to Snore Diary over last 5 nights of 10
|
Continuous
|
Duration of 10 days
|
A293
|
Malapane
|
2014
|
Y
|
N
|
30
|
30
|
N
|
0.0
|
N
|
Tonsillitis pain score (Wong-Baker FACES)
|
Continuous
|
6 days
|
A95
|
McCutcheon
|
1996
|
N
|
N
|
77
|
58
|
N
|
24.7
|
N
|
State Anxiety score
|
Continuous
|
Duration of 15 days
|
A275
|
Naidoo
|
2013
|
Y
|
N
|
30
|
30
|
N
|
0.0
|
N
|
Wheal diameter
|
Continuous
|
4 weeks
|
A100
|
Oberbaum
|
2001
|
N
|
N
|
32
|
30
|
N
|
6.3
|
Y
|
Area-under-the-curve score for stomatitis symptoms (severity and duration) (imputed)
|
Continuous
|
14 days minimum
|
A101
|
bOberbaum
|
2005
|
Y
|
N
|
45
|
40
|
N
|
11.1
|
Y
|
Venous haemoglobin
|
Continuous
|
72 h postpartum
|
A103
|
Padilha
|
2011
|
N
|
N
|
131
|
120
|
Y
|
8.4
|
Y
|
Proportion of workers with Pb decrease of at least 25% (imputed)
|
Dichotomous
|
30 days
|
A104
|
bPapp
|
1998
|
N
|
N
|
372
|
334
|
Y
|
10.2
|
N
|
Proportion of patients with physician-assessed recovery in health (i.e. ‘no symptoms’)
|
Dichotomous
|
By 48 h
|
A105
|
Paris
|
2008
|
N
|
Y
|
131
|
105
|
Y
|
19.8
|
Y
|
Proportion patients with cumulated consumption of morphine < 10 mg/day (imputed)
|
Dichotomous
|
24 h post-op
|
A108
|
bRahlfs
|
1976
|
Y
|
Y
|
?
|
63
|
Y
|
?
|
N
|
Improvement of irritable bowel syndrome (scale 1 + 2)
|
Dichotomous
|
14 days
|
A109
|
bRahlfs
|
1978
|
Y
|
N
|
119
|
85
|
Y
|
28.6
|
N
|
Improvement of irritable bowel syndrome (scale 3 + 4)
|
Dichotomous
|
15 days
|
A277
|
Razlog
|
2012
|
Y
|
N
|
20
|
18
|
N
|
10.0
|
N
|
Conner’s PSQ (‘Impulsivity and/or hyperactivity’ category)
|
Continuous
|
3 weeks
|
A111
|
bReilly
|
1986
|
N
|
Y
|
158
|
109
|
Y
|
31.6
|
N
|
Propn. with improvement in daily overall VAS score (imputed)
|
Dichotomous
|
5 weeks
|
A112
|
bReilly
|
1994
|
N
|
Y
|
28
|
24
|
N
|
14.3
|
Y
|
Propn. with improvement in daily overall VAS score
|
Dichotomous
|
4 weeks
|
A113
|
Robertson
|
2007
|
N
|
Y
|
190
|
111
|
Y
|
41.6
|
N
|
Tonsillectomy pain (VAS) score
|
Continuous
|
14 days
|
A116
|
Schmidt
|
2002
|
N
|
Y
|
208
|
194
|
Y
|
6.7
|
Y
|
Reduction of body weight
|
Continuous
|
3 days
|
A117
|
Seeley
|
2006
|
N
|
N
|
29
|
26
|
N
|
10.3
|
N
|
Area of ecchymosis
|
Continuous
|
10 days
|
A278
|
Sencer
|
2012
|
N
|
Y
|
195
|
106
|
Y
|
45.6
|
N
|
Sum of Walsh scores for mucositis
|
Continuous
|
Up to 20 days post-transplant
|
A120
|
Singer
|
2010
|
N
|
Y
|
80
|
79
|
Y
|
1.3
|
Y
|
Area-under-the-curve pain score
|
Continuous
|
14 days
|
A122
|
Stevinson
|
2003
|
Y
|
N
|
64
|
62
|
N
|
3.1
|
Y
|
Pain (Short Form McGill Pain Questionnaire
|
Continuous
|
14 days
|
A123
|
bTaylor
|
2000
|
N
|
Y
|
51
|
50
|
N
|
2.0
|
Y
|
Daily overall VAS score (imputed)
|
Continuous
|
3–4 weeks
|
A125
|
Tveiten
|
1991
|
N
|
N
|
44
|
36
|
N
|
18.2
|
N
|
Muscle soreness (VAS) (imputed)
|
Continuous
|
3 days
|
A126
|
bTveiten
|
1998
|
N
|
N
|
?
|
46
|
N
|
?
|
N
|
Muscle soreness (VAS)
|
Continuous
|
3 days
|
A128
|
bVickers
|
1998
|
N
|
Y
|
?
|
400
|
Y
|
?
|
Y
|
Muscle soreness (VAS)
|
Continuous
|
2 days
|
A130
|
Weiser
|
1994
|
N
|
Y
|
173
|
155
|
Y
|
10.4
|
N
|
Sinusitis score
|
Continuous
|
5 months or on relapse
|
A131
|
bWiesenauer
|
1985
|
N
|
N
|
106
|
74
|
Y
|
30.2
|
N
|
Symptom relief (nasal): ‘Symptom-free’ + ‘Obvious relief’
|
Dichotomous
|
4 weeks
|
A132
|
Wiesenauer
|
1989
|
N
|
N
|
221
|
152
|
Y
|
31.2
|
N
|
Sinusitis score
|
Continuous
|
3–4 weeks
|
A133
|
bWiesenauer
|
1990
|
N
|
N
|
243
|
171
|
Y
|
29.6
|
N
|
Symptom relief (nasal): ‘Symptom-free’ + ‘Obvious relief’
|
Dichotomous
|
Approx 5 weeks
|
A134
|
Wiesenauer
|
1991
|
N
|
N
|
176
|
106
|
Y
|
39.8
|
N
|
Treatment success
|
Dichotomous
|
12 weeks
|
A135
|
bWiesenauer
|
1995
|
N
|
N
|
132
|
120
|
Y
|
9.1
|
N
|
Symptom relief (nasal): ‘Symptom-free’ + ‘Obvious relief’
|
Dichotomous
|
4 weeks
|
A136
|
Wolf
|
2003
|
Y
|
N
|
60
|
59
|
N
|
1.7
|
N
|
Haematoma area
|
Continuous
|
2 weeks
|
A137
|
Zabolotnyi
|
2007
|
N
|
Y
|
113
|
113
|
Y
|
5.3
|
Y
|
Sinusitis severity score cf. Day 0 (imputed)
|
Continuous
|
7 days
|